Costs Associated with Productivity Loss Among U.S. Patients Newly Diagnosed with Multiple Myeloma Receiving Oral Versus Injectable Chemotherapy

BACKGROUND: The use of novel drug agents in the treatment of multiple myeloma (MM) has been associated with improved therapeutic outcomes and survival; however, MM continues to pose a significant economic burden on patients and health care systems. Evaluating economic implications of therapies can p...

Descripción completa

Detalles Bibliográficos
Autores principales: Merola, David, Yong, Candice, Noga, Stephen J., Shermock, Kenneth M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397991/
https://www.ncbi.nlm.nih.gov/pubmed/30247101
http://dx.doi.org/10.18553/jmcp.2018.24.10.1019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10397991/
https://www.ncbi.nlm.nih.gov/pubmed/30247101
http://dx.doi.org/10.18553/jmcp.2018.24.10.1019

Ejemplares similares